ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: EC: 2.7.11.24; ERK-1; ERT2; Extracellular signal-regulated kinase 1; Insulin-stimulated MAP2 kinase; MAP kinase 3; MAP kinase isoform p44; MAPK 3; MNK1; Microtubule-associated protein 2 kinase; Mitogen-activated protein kinase 3; p44-ERK1
Storage: 2-8C
Application: Western Blotting Analysis: 1:1,000 dilution from a representative lot detected p44 MAPK (ERK1) in Rat C6, L6, and mouse NIH/3T3 cell lysates.Immunoprecipitation Analysis: 100 muL from a representative lot immunoprecipitated p44 MAPK (ERK1) in Rat L6 cell lysate.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected p44 MAPK (ERK1) in rat colon and rat cerebral cortex tissue sections.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany